BAXTER
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Website
Industry
Medical Equipment Manufacturing
Company size
10,001+ employees
38,341 on LinkedIn Includes members with current employer listed as Baxter International Inc., including part-time roles. Also includes employees from subsidiaries: Diagnostic Cardiology at Baxter - U.S. and Hillrom.
Headquarters
Deerfield, Illinois
Specialties
Medical Devices, Biosurgery, Anesthetics, and Pharmacy Automation
MSD
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
MSD products has been present for over 30 years in the GULF region through its local distributors in the UAE, Kuwait, Bahrain, Qatar & Oman and MSD ranks amongst the leading pharmaceutical companies in the region. MSD provides innovative medications in several therapeutic areas, including Anti-Infectives, Diabetes, HCV, HIV, Oncology and Anesthesia in addition to several specialized Vaccines.
For more information, visit www.msd.com and connect with us on Facebook, Linkedin, Youtube and Twitter at MSD GCC.
ABBVIE
AbbVie may have been founded in 2013, but our roots run deep. In 2013, we became a separate company from Abbott, though we share a common legacy and strong prospects for future success.Our name represents our connection to the past and the future. When we became our own company, AbbVie formed a new kind of enterprise—a biopharmaceutical company. We blend the stability, global scale, resources and commercial capabilities of a pharmaceutical company with the focus and culture of a biotech.
Today, our ~30,000 employees around the world focus on delivering transformational medicines and therapies that offer significant patient benefits.
AL FARWANIYA
STADA
At STADA, we follow our purpose of “Caring for People’s Health as a Trusted Partner”. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company.
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for more than 125 years. With our products, we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally.
STADA focuses on a three-pillar strategy consisting of consumer healthcare products, generics, and specialty pharmaceuticals. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. In the financial year 2022, STADA achieved group sales of EUR 3,797.2 million and reported earnings before interest, taxes, depreciation, and amortization (EBITDA) of EUR 884.7 million. As of 31 December 2022, STADA employed 13,183 people worldwide.
CONTACT
Email: anesthesia.conference@maarefah-management.com
Telephone: +971 4 361 9616
© Copyright 2023 | 3rd Annual International Anesthesia and Acute Care Conference